Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Walsh

Showing results (11-20 of 80) with videos related to

Pageof 8
Sort By:
Open Forum Infectious Diseases|December 15, 2021
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.
Vaccine|November 13, 2012
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responsesStephen R Walsh, Michael S Seaman, Lauren E Grandpre, et al.
Open Forum Infectious Diseases|July 31, 2023
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant RecipientsAfoke Kokogho, Trevor A Crowell, Muneerah Aleissa, et al.
Blood Advances|June 7, 2018
Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantationMatthew P Cheng, Alisha Pandit, Joseph H Antin, et al.
ATS Scholar|October 31, 2022
Feasibility of an Antiracism Curriculum in an Academic Pulmonary, Critical Care, and Sleep Medicine DivisionDebasree Banerjee, Nicholas J Nassikas, Parvati Singh, et al.
Frontiers in Public Health|August 12, 2024
Evaluating enrollment and representation in COVID-19 and HIV vaccine clinical trialsDaisy Lezo Ramirez, Emily Koleske, Omolola Ometoruwa, et al.
PLOS Global Public Health|June 8, 2023
Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participantsNicole Espy, Xue Han, Shannon Grant, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
The Journal of Infectious Diseases|March 31, 2010
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with DryvaxMichael S Seaman, Marissa B Wilck, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 31, 2010
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administrationMarissa B Wilck, Michael S Seaman, Lindsey R Baden, et al.
Pageof 8

Showing results (11-20 of 80) with videos related to

Sort By:
Pageof 8
Open Forum Infectious Diseases|December 15, 2021
Safety of Live-Attenuated Measles, Mumps, and Rubella Vaccine Administered Within 2 Years of Hematopoietic Cell TransplantMichaël Desjardins, Xhoi Mitre, Amy C Sherman, et al.
Vaccine|November 13, 2012
Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responsesStephen R Walsh, Michael S Seaman, Lauren E Grandpre, et al.
Open Forum Infectious Diseases|July 31, 2023
SARS-CoV-2 Vaccine-Induced Immune Responses Among Hematopoietic Stem Cell Transplant RecipientsAfoke Kokogho, Trevor A Crowell, Muneerah Aleissa, et al.
Blood Advances|June 7, 2018
Safety and immunogenicity of conjugate quadrivalent meningococcal vaccination after hematopoietic cell transplantationMatthew P Cheng, Alisha Pandit, Joseph H Antin, et al.
ATS Scholar|October 31, 2022
Feasibility of an Antiracism Curriculum in an Academic Pulmonary, Critical Care, and Sleep Medicine DivisionDebasree Banerjee, Nicholas J Nassikas, Parvati Singh, et al.
Frontiers in Public Health|August 12, 2024
Evaluating enrollment and representation in COVID-19 and HIV vaccine clinical trialsDaisy Lezo Ramirez, Emily Koleske, Omolola Ometoruwa, et al.
PLOS Global Public Health|June 8, 2023
Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participantsNicole Espy, Xue Han, Shannon Grant, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challengeUrjeet S Khanwalkar, Jennifer Fields, Joshua A Wiener, et al.
The Journal of Infectious Diseases|March 31, 2010
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with DryvaxMichael S Seaman, Marissa B Wilck, Lindsey R Baden, et al.
The Journal of Infectious Diseases|March 31, 2010
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administrationMarissa B Wilck, Michael S Seaman, Lindsey R Baden, et al.
Pageof 8